AbbVie Contract Manufacturing AbbVie Contract Manufacturing

X

CAS 63095-51-2 manufacturers and suppliers on PharmaCompass

PharmaCompass
(4R)-4-propyloxolan-2-one
Also known as: 63095-51-2, Brivaracetam intermediate 1, (4r)-4-propyloxolan-2-one, 2(3h)-furanone, dihydro-4-propyl-, (r)-, Lp4ge5vl92, (r)-4-propyl-dihydrofuran-2-one
Molecular Formula
C7H12O2
Molecular Weight
128.17  g/mol
InChI Key
NVTUTJMZAZZKAZ-ZCFIWIBFSA-N
FDA UNII
LP4GE5VL92

1 2D Structure

(4R)-4-propyloxolan-2-one

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(4R)-4-propyloxolan-2-one
2.1.2 InChI
InChI=1S/C7H12O2/c1-2-3-6-4-7(8)9-5-6/h6H,2-5H2,1H3/t6-/m1/s1
2.1.3 InChI Key
NVTUTJMZAZZKAZ-ZCFIWIBFSA-N
2.1.4 Canonical SMILES
CCCC1CC(=O)OC1
2.1.5 Isomeric SMILES
CCC[C@@H]1CC(=O)OC1
2.2 Other Identifiers
2.2.1 UNII
LP4GE5VL92
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 63095-51-2

2. Brivaracetam Intermediate 1

3. (4r)-4-propyloxolan-2-one

4. 2(3h)-furanone, Dihydro-4-propyl-, (r)-

5. Lp4ge5vl92

6. (r)-4-propyl-dihydrofuran-2-one

7. (r)-dihydro-4-propyl-2(3h)-furanone

8. (+)-(r)-4-propyl-4,5-dihydrofuran-2(3h)-one

9. Unii-lp4ge5vl92

10. Schembl18263291

11. Amy16477

12. Mfcd29905061

13. Zinc34596195

14. (r)-dihydro-4-propylfuran-2(3h)-one

15. S10720

16. Ac-29290

17. Ds-19249

18. Cs-0090076

19. A857888

2.4 Create Date
2006-10-26
3 Chemical and Physical Properties
Molecular Weight 128.17 g/mol
Molecular Formula C7H12O2
XLogP31.5
Hydrogen Bond Donor Count0
Hydrogen Bond Acceptor Count2
Rotatable Bond Count2
Exact Mass128.083729621 g/mol
Monoisotopic Mass128.083729621 g/mol
Topological Polar Surface Area26.3 Ų
Heavy Atom Count9
Formal Charge0
Complexity110
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag China
Digital Content Digital Content
URL Supplier Web Content
7682-20-4
Brivaracetam
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary locat...
Founded in 2003, Senary Chem is one of the Key High-Tech Enterprises of National Torch Plan. Senary located in National Cangzhou Lingang Economic and Technological Development Zone,Cangzhou City,Hebei Province. Senary cover an area of 67,000 square meters, and 300 professionals work there. Senary R&D organization recognized as the Hebei Provincial Engineering Technology Center is comprised of two R & D centers in Tianjin and Cangzhou, and it employs 80 experienced scientists in total. Senary focus on the development, production and sales of advanced pharmaceutical intermediates. Especially, Senary has leading technology and manufacturing capacity for diabetes drug intermediates. All intermediates of DPP4 and SGLT2 class drugs on market have been commercialized production. Senary has 150 sets of 50 ~ 8000L reactor with annual production capacity of 1,000 tons, which can handle both low and high temperature reactions within -100 ~ 240 ℃ range, all kinds of catalytic reactions within 0 ~ 5MPa pressure, and moisture and/or oxygen sensitive reactions. Senary also has expertise in chiral synthesis with leading technologies. The advanced sewage treatment system at Senery has processing capacity of 600 tons daily. Senary has an excellent team that has rich quality management experience.We have established a set of normative and perfect quality managment system,monitoring the whole process of risk assessment,R&D,transfer from pilot scale to commercial production,manufacturing,analysis and sales service. Senary will continue to dedicate on the field of pharmaceutical intermediates to provide the best service for domestic and foreign API pharmaceutical companies with high quality and timely supply of products.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY